Works matching AU Chang, Chao-Hsiang


Results: 78
    1
    2
    3
    4
    5

    First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 4, p. 406, doi. 10.1093/jjco/hyae182
    By:
    • Chung, Hsiao-Jen;
    • Kondoh, Chihiro;
    • Bae, Woo Kyun;
    • Tamada, Satoshi;
    • Matsubara, Nobuaki;
    • Lee, Hyo Jin;
    • Mizuno, Ryuichi;
    • Anai, Satoshi;
    • Kimura, Go;
    • Tomita, Yoshihiko;
    • Chang, Chao-Hsiang;
    • Chang, John Wen-Cheng;
    • Lin, Jianxin;
    • Perini, Rodolfo F;
    • Molife, L Rhoda;
    • Powles, Thomas;
    • Rini, Brian I;
    • Uemura, Hirotsugu
    Publication type:
    Article
    6
    7
    8

    Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-98696-0
    By:
    • Sheu, Zai-Lin;
    • Huang, Chi-Ping;
    • Chang, Chao-Hsiang;
    • Chen, Chung-Hsin;
    • Hong, Jian-Hua;
    • Weng, Han-Yu;
    • Tai, Ta-Yao;
    • Chung, Shiu-Dong;
    • Lo, Chi-Wen;
    • Hsueh, Thomas Y.;
    • Tsai, Yao-Chou;
    • Jiang, Yuan-Hong;
    • Chiang, Bing-Juin;
    • Chen, Yung-Tai;
    • Lin, Jen-Tai;
    • Lin, Wei-Yu;
    • Jou, Yeong-Chin;
    • Tseng, Jen-Shu;
    • Wu, Chia-Chang;
    • Wu, Wen‑Jeng
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Development and validation of a prediction model for early recurrence in upper tract urothelial carcinoma treated with radical nephroureterectomy.

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14180-2
    By:
    • Chou, Yi-Ju;
    • Luo, Hao-Lun;
    • Wang, Hung-Jen;
    • Huang, Steven K.;
    • Hsieh, Yu-Che;
    • Wu, Wen-Jeng;
    • Li, Ching-Chia;
    • Weng, Han-Yu;
    • Tai, Ta-Yao;
    • Chang, Chao-Hsiang;
    • Wu, Hsi-Chin;
    • Lin, Po-Hung;
    • Pang, Jacob See-Tong;
    • Chen, Chung-Hsin;
    • Hong, Jian-Hua;
    • Tseng, Jen-Shu;
    • Chen, Marcelo;
    • Chen, I-Hsuan Alan;
    • Yu, Chia-Cheng;
    • Chen, Pi-Che
    Publication type:
    Article
    15
    16
    17
    18
    19

    Prognostic factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.

    Published in:
    World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-023-04700-9
    By:
    • Chen, Chen-Ya;
    • Chang, Chao-Hsiang;
    • Yang, Chi-Rei;
    • Hsieh, Kun-Lin;
    • Tsing, Wen-Hsin;
    • Chen, I-Hsuan Alan;
    • Lin, Jen-Tai;
    • Huang, Chao-Yuan;
    • Hong, Jian-Hua;
    • Tseng, Jen-Shu;
    • Lin, Wun-Rong;
    • Tsai, Yao-Chou;
    • Wu, Shu-Yu;
    • Shen, Cheng-Huang;
    • Cheong, Ian-Seng;
    • Chen, Chuan-Shu;
    • Yang, Cheng-Kuang;
    • Jiang, Yuan-Hong;
    • Tsai, Chung-You;
    • Hsueh, Thomas Y.
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone—A Retrospective Study.

    Published in:
    Cancers, 2023, v. 15, n. 13, p. 3516, doi. 10.3390/cancers15133516
    By:
    • Chen, Hao Xiang;
    • Tsai, Li-Hsien;
    • Chang, Chao-Hsiang;
    • Wu, Hsi-Chin;
    • Lin, Ching-Chan;
    • Lin, Che-Hung;
    • Yeh, Chin-Chung;
    • Yang, Chi-Rei;
    • Lien, Chi-Shun;
    • Chang, Yi-Huei;
    • Liang, Ji-An;
    • Chen, Guan-Heng;
    • Hsiao, Po-Jen;
    • Hsieh, Po-Fan;
    • Huang, Chi-Ping
    Publication type:
    Article
    31
    32
    33
    34
    35

    Bladder calculi in Taiwan.

    Published in:
    Urological Science, 2019, v. 30, n. 2, p. 53, doi. 10.4103/UROS.UROS_142_18
    By:
    • Laih, Chun-Yo;
    • Chang, Chao-Hsiang;
    • Chen, Wen-Chi
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50